Capricor Therapeutics, Inc. (CAPR)
6.615
+0.38
(+6.18%)
USD |
NASDAQ |
Oct 29, 16:00
6.67
+0.06
(+0.83%)
After-Hours: 20:00
Capricor Therapeutics Total Return Level : 6.23 for Oct. 28, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 28, 2026 | 6.23 |
| October 27, 2026 | 6.10 |
| October 26, 2026 | 5.74 |
| October 23, 2026 | 5.93 |
| October 22, 2026 | 6.13 |
| October 21, 2026 | 5.88 |
| October 20, 2026 | 6.61 |
| October 19, 2026 | 6.65 |
| October 16, 2026 | 6.71 |
| October 15, 2026 | 7.27 |
| October 14, 2026 | 6.59 |
| October 13, 2026 | 6.88 |
| October 12, 2026 | 7.47 |
| October 09, 2026 | 7.83 |
| October 08, 2026 | 8.01 |
| October 07, 2026 | 8.10 |
| October 06, 2026 | 7.75 |
| October 05, 2026 | 7.78 |
| October 02, 2026 | 8.95 |
| October 01, 2026 | 8.94 |
| September 30, 2026 | 9.47 |
| September 29, 2026 | 8.57 |
| September 28, 2026 | 8.71 |
| September 25, 2026 | 8.36 |
| September 24, 2026 | 8.57 |
| Date | Value |
|---|---|
| September 23, 2026 | 8.67 |
| September 22, 2026 | 9.34 |
| September 21, 2026 | 8.90 |
| September 18, 2026 | 9.06 |
| September 17, 2026 | 9.42 |
| September 16, 2026 | 8.56 |
| September 15, 2026 | 8.56 |
| September 14, 2026 | 8.81 |
| September 11, 2026 | 8.37 |
| September 10, 2026 | 8.30 |
| September 09, 2026 | 8.64 |
| September 08, 2026 | 9.06 |
| September 04, 2026 | 9.40 |
| September 03, 2026 | 9.28 |
| September 02, 2026 | 9.89 |
| September 01, 2026 | 10.01 |
| August 31, 2026 | 9.91 |
| August 28, 2026 | 9.59 |
| August 27, 2026 | 10.06 |
| August 26, 2026 | 9.36 |
| August 25, 2026 | 8.29 |
| August 24, 2026 | 6.80 |
| August 21, 2026 | 6.29 |
| August 20, 2026 | 6.835 |
| August 19, 2026 | 7.98 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ARS Pharmaceuticals, Inc. | 3.65 |
| SELLAS Life Sciences Group, Inc. | 10.38 |
| Sionna Therapeutics, Inc. | 4.04 |
| Alnylam Pharmaceuticals, Inc. | 232.40 |
| Cytokinetics, Inc. | 61.28 |